⌘K

Login Start Free

Home/Filings/5/0001209191-23-007395

5//SEC Filing

Janda Kim 5

Accession 0001209191-23-007395

CIK 0000850261other

View on SEC.gov Company Profile

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 9:10 PM ET

Size

4.8 KB

Accession

0001209191-23-007395

Insider Transaction Report

Form 5

Period: 2021-12-31

Sorrento Therapeutics, Inc.SRNE

Director

Transactions

Sale
Common Stock
2021-03-15$10.42/sh−3,000$31,273→ 0 total

Footnotes (1)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Documents

1 file

5
doc5.xmlPrimary
FORM 5 SUBMISSION

Issuer

Sorrento Therapeutics, Inc.

CIK 0000850261

Entity typeother

Related Parties

1

filerCIK 0001518466

Filing Metadata

Form type: 5
Filed: Feb 5, 7:00 PM ET
Accepted: Feb 6, 9:10 PM ET
Size: 4.8 KB

View on SEC.gov